CELLULARLINE SPA (CELL.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:CELL - IT0005244618 - Common Stock
2.55 EUR
+0.01 (+0.39%)
Taking everything into account, CELL scores 5 out of 10 in our fundamental rating. CELL was compared to 31 industry peers in the Technology Hardware, Storage & Peripherals industry. CELL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CELL is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CELL had positive earnings in the past year.
In the past year CELL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CELL reported negative net income in multiple years.
CELL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CELL has a Return On Assets of 2.60%. This is comparable to the rest of the industry: CELL outperforms 54.84% of its industry peers.
Looking at the Return On Equity, with a value of 4.27%, CELL is in line with its industry, outperforming 58.06% of the companies in the same industry.
CELL has a Return On Invested Capital (4.42%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.6% | ||
| ROE | 4.27% | ||
| ROIC | 4.42% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of CELL (3.44%) is comparable to the rest of the industry.
CELL's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 4.91%, CELL is in the better half of the industry, outperforming 61.29% of the companies in the same industry.
In the last couple of years the Operating Margin of CELL has declined.
CELL has a better Gross Margin (40.07%) than 61.29% of its industry peers.
CELL's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.91% | ||
| PM (TTM) | 3.44% | ||
| GM | 40.07% |
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
2. Health
2.1 Basic Checks
CELL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CELL has been reduced compared to 1 year ago.
The number of shares outstanding for CELL has been reduced compared to 5 years ago.
The debt/assets ratio for CELL has been reduced compared to a year ago.
2.2 Solvency
CELL has an Altman-Z score of 2.34. This is not the best score and indicates that CELL is in the grey zone with still only limited risk for bankruptcy at the moment.
CELL has a Altman-Z score (2.34) which is comparable to the rest of the industry.
CELL has a debt to FCF ratio of 2.46. This is a good value and a sign of high solvency as CELL would need 2.46 years to pay back of all of its debts.
CELL has a Debt to FCF ratio of 2.46. This is in the better half of the industry: CELL outperforms 70.97% of its industry peers.
CELL has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
CELL has a better Debt to Equity ratio (0.13) than 80.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 2.46 | ||
| Altman-Z | 2.34 |
ROIC/WACC0.49
WACC8.97%
2.3 Liquidity
A Current Ratio of 2.12 indicates that CELL has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.12, CELL is in the better half of the industry, outperforming 61.29% of the companies in the same industry.
CELL has a Quick Ratio of 1.33. This is a normal value and indicates that CELL is financially healthy and should not expect problems in meeting its short term obligations.
CELL's Quick ratio of 1.33 is fine compared to the rest of the industry. CELL outperforms 64.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.33 |
3. Growth
3.1 Past
CELL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.78%, which is quite impressive.
CELL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.43% yearly.
Looking at the last year, CELL shows a small growth in Revenue. The Revenue has grown by 3.54% in the last year.
Measured over the past years, CELL shows a small growth in Revenue. The Revenue has been growing by 3.18% on average per year.
EPS 1Y (TTM)60.78%
EPS 3YN/A
EPS 5Y-20.43%
EPS Q2Q%-4.76%
Revenue 1Y (TTM)3.54%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%-2.91%
3.2 Future
Based on estimates for the next years, CELL will show a small growth in Earnings Per Share. The EPS will grow by 2.47% on average per year.
Based on estimates for the next years, CELL will show a decrease in Revenue. The Revenue will decrease by -0.60% on average per year.
EPS Next Y-15%
EPS Next 2Y2.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.17%
Revenue Next 2Y-0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 9.81, which indicates a very decent valuation of CELL.
CELL's Price/Earnings ratio is rather cheap when compared to the industry. CELL is cheaper than 87.10% of the companies in the same industry.
When comparing the Price/Earnings ratio of CELL to the average of the S&P500 Index (26.50), we can say CELL is valued rather cheaply.
With a Price/Forward Earnings ratio of 5.95, the valuation of CELL can be described as very cheap.
CELL's Price/Forward Earnings ratio is rather cheap when compared to the industry. CELL is cheaper than 96.77% of the companies in the same industry.
CELL is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.93, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.81 | ||
| Fwd PE | 5.95 |
4.2 Price Multiples
CELL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CELL is cheaper than 93.55% of the companies in the same industry.
CELL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CELL is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.74 | ||
| EV/EBITDA | 2.97 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.47%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CELL has a Yearly Dividend Yield of 3.62%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 0.89, CELL pays a better dividend. On top of this CELL pays more dividend than 93.55% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, CELL pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.62% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CELL pays out 34.37% of its income as dividend. This is a sustainable payout ratio.
DP34.37%
EPS Next 2Y2.47%
EPS Next 3YN/A
BIT:CELL (12/22/2025, 7:00:00 PM)
2.55
+0.01 (+0.39%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners4.94%
Inst Owner ChangeN/A
Ins Owners19.57%
Ins Owner ChangeN/A
Market Cap55.77M
Revenue(TTM)164.26M
Net Income(TTM)5.65M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.62% |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP34.37%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.77%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.86%
EPS NY rev (3m)-30.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-11.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.81 | ||
| Fwd PE | 5.95 | ||
| P/S | 0.34 | ||
| P/FCF | 3.74 | ||
| P/OCF | 2.75 | ||
| P/B | 0.42 | ||
| P/tB | 1.02 | ||
| EV/EBITDA | 2.97 |
EPS(TTM)0.26
EY10.2%
EPS(NY)0.43
Fwd EY16.8%
FCF(TTM)0.68
FCFY26.75%
OCF(TTM)0.93
OCFY36.4%
SpS7.51
BVpS6.05
TBVpS2.49
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.6% | ||
| ROE | 4.27% | ||
| ROCE | 5.04% | ||
| ROIC | 4.42% | ||
| ROICexc | 5.33% | ||
| ROICexgc | 12.93% | ||
| OM | 4.91% | ||
| PM (TTM) | 3.44% | ||
| GM | 40.07% | ||
| FCFM | 9.08% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y46.34%
ROICexgc growth 5Y-17.53%
ROICexc growth 3Y77.77%
ROICexc growth 5Y-8.95%
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
F-Score4
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 2.46 | ||
| Debt/EBITDA | 0.81 | ||
| Cap/Depr | 39.19% | ||
| Cap/Sales | 3.28% | ||
| Interest Coverage | 2.77 | ||
| Cash Conversion | 93.13% | ||
| Profit Quality | 264.18% | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.33 | ||
| Altman-Z | 2.34 |
F-Score4
WACC8.97%
ROIC/WACC0.49
Cap/Depr(3y)26.8%
Cap/Depr(5y)35.01%
Cap/Sales(3y)3.22%
Cap/Sales(5y)4.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.78%
EPS 3YN/A
EPS 5Y-20.43%
EPS Q2Q%-4.76%
EPS Next Y-15%
EPS Next 2Y2.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.54%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%-2.91%
Revenue Next Year-6.17%
Revenue Next 2Y-0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.25%
EBIT growth 3Y54.08%
EBIT growth 5Y-17%
EBIT Next Year25.99%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1050.19%
FCF growth 3Y4.84%
FCF growth 5Y6.28%
OCF growth 1Y730.91%
OCF growth 3Y4.12%
OCF growth 5Y1.2%
CELLULARLINE SPA / CELL.MI FAQ
What is the ChartMill fundamental rating of CELLULARLINE SPA (CELL.MI) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CELL.MI.
What is the valuation status of CELLULARLINE SPA (CELL.MI) stock?
ChartMill assigns a valuation rating of 7 / 10 to CELLULARLINE SPA (CELL.MI). This can be considered as Undervalued.
What is the profitability of CELL stock?
CELLULARLINE SPA (CELL.MI) has a profitability rating of 4 / 10.
How financially healthy is CELLULARLINE SPA?
The financial health rating of CELLULARLINE SPA (CELL.MI) is 7 / 10.
What is the expected EPS growth for CELLULARLINE SPA (CELL.MI) stock?
The Earnings per Share (EPS) of CELLULARLINE SPA (CELL.MI) is expected to decline by -15% in the next year.